Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer von Douillard, Jean-Yves, Peschel, Christian, Shepherd, Frances, Paz-Ares, Luis, Arnold, Andrew, Davis, Mary, Tonato, Maurizio, Smylie, Michael, Tu, Dongsheng, Voi, Maurizio, Humphrey, Jeffrey, Ottaway, Jon, Young, Katherine, Vreckem, Anne Van, Seymour, Lesley

Volltext

Phase I Pharmacokinetic and Pharmacodynamic Study of Weekly 1-Hour and 24-Hour Infusion BMS-214662, a Farnesyltransferase Inhibitor, in Patients With Advanced Solid Tumors von TABERNERO, Josep, ROJO, Fredy, VAN VRECKEM, Anne, BELLMUNT, Joaquim, MANNE, Veeraswamy, MANNING, James A, GARRIDO, Carmen, FELIP, Enriqueta, DEL CAMPO, Josep Maria, GARCIA, Monica, VALVERDE, Sonia, BASELGA, José, MARIMON, Irene, VOI, Maurizio, ALBANELL, Joan, GUIX, Marta, VDZQUEZ, Federico, CARULLA, Joan, COOPER, Michael, ANDREU, Jordi

Volltext

A Phase I Pharmacokinetic and Pharmacodynamic Study of the Farnesyl Transferase Inhibitor BMS-214662 in Combination with Cisplatin in Patients with Advanced Solid Tumors von MACKAY, Helen J, HOEKSTRA, Ronald, ESKENS, Ferry A. L. M, LOOS, Walker J, CRAWFORD, Donna, VOI, Maurizio, VAN VRECKEM, Anne, EVANS, T. R, VERWEIJ, Jaap

Volltext